Yamatani K - Search Results

1

Hyperglycemia is a factor for an increase in serum ceruloplasmin in type 2 diabetes.

Daimon M, Susa S, Yamatani K, Manaka H, Hama K, Kimura M, Ohnuma H, Kato T. Daimon M, et al. Among authors: yamatani k. Diabetes Care. 1998 Sep;21(9):1525-8. doi: 10.2337/diacare.21.9.1525. Diabetes Care. 1998. PMID: 9727903

2

A nonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus.

Daimon M, Kato T, Kawanami T, Tominaga M, Igarashi M, Yamatani K, Sasaki H. Daimon M, et al. Among authors: yamatani k. Biochem Biophys Res Commun. 1995 Dec 5;217(1):89-95. doi: 10.1006/bbrc.1995.2749. Biochem Biophys Res Commun. 1995. PMID: 8526944

3

NIDDM with a ceruloplasmin gene mutation.

Daimon M, Yamatani K, Tominaga M, Manaka H, Kato T, Sasaki H. Daimon M, et al. Among authors: yamatani k. Diabetes Care. 1997 Apr;20(4):678. doi: 10.2337/diacare.20.4.678a. Diabetes Care. 1997. PMID: 9097006 No abstract available.

4

Insulin inhibits glucagon-induced glycogenolysis normally in perivenous hepatocytes of Wistar fatty rats.

Ikezawa Y, Yamatani K, Ohnuma H, Daimon M, Manaka H, Sasaki H. Ikezawa Y, et al. Among authors: yamatani k. Diabetes Res Clin Pract. 2005 Aug;69(2):120-3. doi: 10.1016/j.diabres.2004.12.008. Diabetes Res Clin Pract. 2005. PMID: 16005360

5

Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion.

Fukase N, Takahashi H, Manaka H, Igarashi M, Yamatani K, Daimon M, Sugiyama K, Tominaga M, Sasaki H. Fukase N, et al. Among authors: yamatani k. Diabetes Res Clin Pract. 1992 Mar;15(3):187-95. doi: 10.1016/0168-8227(92)90024-l. Diabetes Res Clin Pract. 1992. PMID: 1576919

6

Sepsis inhibits insulin-stimulated glucose transport in isolated rat adipocytes.

Igarashi M, Yamatani K, Fukase N, Daimon M, Ohnuma H, Takahashi H, Manaka H, Tominaga M, Sasaki H. Igarashi M, et al. Among authors: yamatani k. Diabetes Res Clin Pract. 1992 Mar;15(3):213-8. doi: 10.1016/0168-8227(92)90027-o. Diabetes Res Clin Pract. 1992. PMID: 1576921

7

Fine structure of the human ceruloplasmin gene.

Daimon M, Yamatani K, Igarashi M, Fukase N, Kawanami T, Kato T, Tominaga M, Sasaki H. Daimon M, et al. Among authors: yamatani k. Biochem Biophys Res Commun. 1995 Mar 28;208(3):1028-35. doi: 10.1006/bbrc.1995.1437. Biochem Biophys Res Commun. 1995. PMID: 7702601

8

Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients.

Fukase N, Igarashi M, Takahashi H, Manaka H, Yamatani K, Daimon M, Tominaga M, Sasaki H. Fukase N, et al. Among authors: yamatani k. Diabet Med. 1993 Jan-Feb;10(1):44-9. doi: 10.1111/j.1464-5491.1993.tb01995.x. Diabet Med. 1993. PMID: 8435987

9

Dinucleotide repeat polymorphism in the human ceruloplasmin gene.

Daimon M, Morita Y, Yamatani K, Igarashi M, Fukase N, Kawanami T, Kato T, Tominaga M, Sasaki H. Daimon M, et al. Among authors: yamatani k. Hum Genet. 1995 Dec;96(6):736. doi: 10.1007/BF00210309. Hum Genet. 1995. PMID: 8522337

10

Response of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide to glucose ingestion in non-insulin dependent diabetes mellitus. Effect of sulfonylurea therapy.

Fukase N, Manaka H, Sugiyama K, Takahashi H, Igarashi M, Daimon M, Yamatani K, Tominaga M, Sasaki H. Fukase N, et al. Among authors: yamatani k. Acta Diabetol. 1995 Oct;32(3):165-9. doi: 10.1007/BF00838486. Acta Diabetol. 1995. PMID: 8590785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters